Volume 86, Issue 1 , Pages 51-59, January 2012
Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content☆
Abstract
Objective
The purpose of this randomized, controlled, parallel group study was to characterize the relationships between dosages of stearidonic acid (SDA) and eicosapentaenoic acid (EPA), and incorporation of EPA into red blood cell (RBC) membranes over time.
Methods
Healthy subjects (n=131) received capsules with placebo (safflower oil), SDA (0.43, 1.3, 2.6, or 5.2
g/d) or EPA (0.44, 1.3, or 2.7
g/d) for 12 weeks. RBC fatty acids were analyzed biweekly.
Results
RBC %EPA increased in all EPA and SDA groups (p<0.02 vs. control) except the 0.43
g/d SDA group (p=0.187). For theoretical intakes of EPA of 0.25, 0.5, and 0.89
g/d, the amounts of SDA needed to achieve equivalent RBC EPA enrichment were 0.61, 1.89, and 5.32
g/d (conversion efficiencies of 41%, 26%, and 17%), respectively.
Conclusions
SDA increased RBC %EPA in a dosage and time-dependent manner at intakes as low as 1.3
g/d.
Keywords: Omega-3 fatty acids, Eicosapentaenoic acid, Stearidonic acid, RBC, Dosage-response
To access this article, please choose from the options below
☆ This trial was funded by Solae LLC, St. Louis, MO and Monsanto Company.
PII: S0952-3278(11)00147-5
doi:10.1016/j.plefa.2011.10.005
© 2011 Elsevier Ltd. All rights reserved.
Volume 86, Issue 1 , Pages 51-59, January 2012
